New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 6, 2013
07:39 EDTHZNPHorizon Pharma announces Notice of Allowance from USPTO covering Rayos
Horizon Pharma announced that Skyepharma has received a Notice of Allowance from the United States Patent and Trademark Office, or USPTO, for U.S. Patent Application 13/428,548 entitled "Delayed Release Tablet with Defined Core Geometry" that covers the company's U.S. approved product Rayos. This Notice of Allowance concludes the substantive examination of the patent application and will result in the issuance of a U.S. patent after administrative processes are completed. The U.S. patent scheduled to issue from this application will expire in 2024. After issuance, Horizon plans to list the U.S. patent in the FDA's Approved Drug Products with Therapeutic Equivalence Evaluations, or Orange Book. This will be the third U.S. patent to be listed in the Orange Book for Rayos.
News For HZNP From The Last 14 Days
Check below for free stories on HZNP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2014
11:48 EDTHZNPOptions with increasing implied volatility
Subscribe for More Information
July 29, 2014
10:00 EDTHZNPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:43 EDTHZNPHorizon Pharma downgraded to Neutral from Overweight at Piper Jaffray
Subscribe for More Information
July 28, 2014
13:03 EDTHZNPHorizon Pharma shares offer 'significant value,' says Stifel
Subscribe for More Information
12:21 EDTHZNPOn The Fly: Midday Wrap
Subscribe for More Information
09:17 EDTHZNPOn The Fly: Pre-market Movers
Subscribe for More Information
06:22 EDTHZNPHorizon Pharma said Duexis, Vimovo to be placed on CVS, Express exlclusion lists
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use